HUM
43
2
DGX
46
3
FLS
55
3
C
71
-10
EQT
54
4
R
62
-4
BSX
63
-3
AMAT
63
-3
SWK
39
-10
JCI
70
2
EBAY
49
-10
CNP
62
12
TMO
44
-2
NWS
76
2
KMB
42
2
MMC
50
2
APA
31
-3
GME
46
4
HST
52
-2
MS
59
-2
HUM
43
2
DGX
46
3
FLS
55
3
C
71
-10
EQT
54
4
R
62
-4
BSX
63
-3
AMAT
63
-3
SWK
39
-10
JCI
70
2
EBAY
49
-10
CNP
62
12
TMO
44
-2
NWS
76
2
KMB
42
2
MMC
50
2
APA
31
-3
GME
46
4
HST
52
-2
MS
59
-2
Financhill
Back

Beta Bionics 10K Form

Sell
18

BBNX
Beta Bionics

Last Price:
$13.13
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BBNX News And Ratings

See the #1 stock for the next 7 days that we like better than BBNX

BBNX Financial Statistics

Sales & Book Value

Annual Sales: $65.1M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 1.75

Profitability

Net Income (TTM): $0
Gross Margin: $35.9M
Return on Equity: 0%
Return on Assets: 0%

Beta Bionics Earnings Forecast

Key Beta Bionics Financial Ratios

  • The Gross Profit Margin over the past 3 years for BBNX is 55.11%.
  • The Selling, General & Administrative Expenses for BBNX have been equal to 84.39% of Gross Profit Margin.
  • The Research & Development expenses have been 40.21% of Revenue.
  • The Net Earning history of BBNX is -84.08% of Total Revenues.
  • Per Share Earnings over the last 3 years have been positive in 2 years.

Beta Bionics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Current Symbol: BBNX
Website: betabionics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BBNX Technical Analysis vs Fundamental Analysis

Sell
18
Beta Bionics (BBNX) is a Sell

Is Beta Bionics a Buy or a Sell?

  • Beta Bionics stock is rated a Sell
    The current Beta Bionics [BBNX] share price is $12.66. The Score for BBNX is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.